Plus Therapeutics Inc - Company Profile

Powered by

All the data and insights you need on Plus Therapeutics Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Plus Therapeutics Inc Strategy Report

  • Understand Plus Therapeutics Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Plus Therapeutics Inc: Executives

The following section provides information on Plus Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Plus Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Richard J. Hawkins

Chairman Executive Board Since: 2018 Age: 75

Mr. Richard J. Hawkins has been the Chairman of the company since 2018. He joined Cytori Therapeutics as a Director in 2007. He is also the Chief Executive Officer of Lumos Pharma, Inc. Earlier, he founded LabNow Inc and served as the Chief Executive Officer (CEO) and Chairman of the company from 2004 to 2009. Mr. Hawkins founded Pharmaco, a clinical drug development services company and served as the CEO, Chairman and President. He is also the founder of id2, Concave Biotechnology and Sensus Drug Development Corp. Previously, he served as the Chairman of LoopOne Inc.

Read Hide full bio of Richard J. Hawkins

Marc H. Hedrick, M.D.

Chief Executive Officer; Director; President Executive Board Since: 2014 Age: 60

Dr. Marc H. Hedrick has been the President, the Chief Executive Officer and a Director of the company since 2014. He joined Cytori as the Chief Scientific Officer and Medical Director in October 2002. Previously, Mr. Hedrick co-founded, and served as the President and Chief Executive Officer of StemSource, Inc. He is also a plastic surgeon and a former Associate Professor of Surgery and Pediatrics at the University of California, Los Angeles (UCLA). From 1998 to 2005, Dr. Hedrick directed the Laboratory of Regenerative Bioengineering and Repair for the Department of Surgery at UCLA.

Read Hide full bio of Marc H. Hedrick, M.D.

Andrew Sims

Chief Financial Officer; Vice President Senior Management Since: 2020 Age: 50

Mr Andrew J. Sims has been the Chief Financial Officer and Vice President of the company since 2020. Prior to this, he served as the Chief Financial Officer at various private equity firms. He also served as partner at Mazars, a global accounting, advisory, audit, tax and consulting firm.

Read Hide full bio of Andrew Sims

Norman LaFrance

Senior Vice President; Chief Medical Officer Senior Management Since: 2021 Age: 75

Mr. Norman LaFrance has been the Chief Medical Officer and the Senior Vice President of the company since 2021. Previously, he served as the Chief Medical Officer and Senior Vice President of Jubiliant Pharma Ltd from 2012 to 2022.

Read Hide full bio of Norman LaFrance

Russ Havranek

Vice President - Corporate Strategy and New Product Planning Senior Management Since: 2014
Gain a 360-degree view of Plus Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Plus Therapeutics Inc and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code